Methods and Protocols (Jan 2021)

The Past, Present and Future of Flow Cytometry in Central Nervous System Malignancies

  • Evrysthenis Vartholomatos,
  • George Vartholomatos,
  • George A. Alexiou,
  • Georgios S. Markopoulos

DOI
https://doi.org/10.3390/mps4010011
Journal volume & issue
Vol. 4, no. 1
p. 11

Abstract

Read online

Central nervous system malignancies (CNSMs) are categorized among the most aggressive and deadly types of cancer. The low median survival in patients with CNSMs is partly explained by the objective difficulties of brain surgeries as well as by the acquired chemoresistance of CNSM cells. Flow Cytometry is an analytical technique with the ability to quantify cell phenotype and to categorize cell populations on the basis of their characteristics. In the current review, we summarize the Flow Cytometry methodologies that have been used to study different phenotypic aspects of CNSMs. These include DNA content analysis for the determination of malignancy status and phenotypic characterization, as well as the methodologies used during the development of novel therapeutic agents. We conclude with the historical and current utility of Flow Cytometry in the field, and we propose how we can exploit current and possible future methodologies in the battle against this dreadful type of malignancy.

Keywords